Alzheimer’s Disease and Gingko Biloba

NewsGuard 100/100 Score

What is Ginkgo Biloba?

Ginkgo biloba is a tree that is native to China and has been used in traditional Chinese medicine and cuisine for centuries. Extracts of Ginkgo biloba are often sold as food supplements with potential medicinal uses ranging from treating high blood pressure to altitude sickness.

The efficacy of Ginkgo extracts for the treatment of such conditions is not proven, although many people report beneficial effects. As Gingko Biloba is thought to be involved in blood flow regulation (being an antioxidant and having anti-inflammatory properties), many have speculated that it may be beneficial in dementia.

Ginko Biloba pictures of leaf, powdered form and medicinal tablets - a photo by Heike Brauer

Heike Brauer | Shutterstock

What have studies shown?

Ginkgo biloba extract (EGb761) has been widely used to treat cognitive decline across Europe since 2000 as an alternative medicine, and used in some small scale clinical trials.

According to one recent systematic review, high dosages of EGb (240 mg/day) taken for at least 5 or 6 months may have beneficial effects on dementia sufferers compared to those taking 200 mg/day or less. Compared to placebo controls, those taking 240 mg/day of EGb761 had a slightly better recovery in terms of activities of daily living and overall cognitive performance.

Other studies have shown no overall beneficial effect of EGb on the treatment or prevention of Alzheimer’s disease. For example, the Ginkgo Evaluation of Memory (GEM) study found no significant beneficial effects of Gingko in reducing dementia or enhancing cognitive performance. This study included over 3000 participants; the largest of its kind. Furthermore, there were no differences between sex, ethnicity or baseline cognitive scores.

Can EGb761 prevent or treat Alzheimer’s disease?

Extensive analyses of the multiple studies performed to analyze the efficacy of EGb761 in the treatment of dementia have shown mixed results. Some show that high dosages may have moderately beneficial effects in slowing down cognitive decline, whereas others have shown no difference between those taking Gingko and those taking placebos.

In common with most alternative medicines, the majority of large-scale studies do not seem to show any significant effects of such medicines on the positive treatment of health conditions. When considering alternative medicines such as Gingko Biloba, patients and caregivers should not forgo conventional medicines and therapies in favor of alternative medicines whose efficacy is not proven.

However, a majority of herbal medicines do not cause any significant harm or side-effects, and may be used in conjunction with conventional medicines, providing the physician does not outline any specific harmful interactions e.g. warfarin and EGb761.


EGb761 may potentially have moderately beneficial effects in preventing or slowing down cognitive decline in Alzheimer’s disease. However, a majority of studies have not proved that it has significant positive effects in the treatment and prevention of dementia or cognitive decline, despite its wide usage. Using EGb761 in combination with conventional medicines may be beneficial, but relying on herbal medicines such as EGb761 alone is not recommended.

Further Reading

Last Updated: May 17, 2023

Dr. Osman Shabir

Written by

Dr. Osman Shabir

Osman is a Postdoctoral Research Associate at the University of Sheffield studying the impact of cardiovascular disease (atherosclerosis) on neurovascular function in vascular dementia and Alzheimer's disease using pre-clinical models and neuroimaging techniques. He is based in the Department of Infection, Immunity & Cardiovascular Disease in the Faculty of Medicine at Sheffield.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Shabir, Osman. (2023, May 17). Alzheimer’s Disease and Gingko Biloba. News-Medical. Retrieved on May 29, 2024 from

  • MLA

    Shabir, Osman. "Alzheimer’s Disease and Gingko Biloba". News-Medical. 29 May 2024. <>.

  • Chicago

    Shabir, Osman. "Alzheimer’s Disease and Gingko Biloba". News-Medical. (accessed May 29, 2024).

  • Harvard

    Shabir, Osman. 2023. Alzheimer’s Disease and Gingko Biloba. News-Medical, viewed 29 May 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Alzheimer's may worsen COVID-19 outcomes via olfactory mucosa changes